Therapeutic Options for Occult Breast Cancer: a Survey of the American Society of Breast Surgeons and Review of the Literature
Overview
Authors
Affiliations
Background: Axillary presentation of occult breast cancer (OBC) is uncommon, and continues to be a diagnostic and therapeutic challenge to physicians. After our recent experience with a similar patient, a survey of the American Society of Breast Surgeons (ASBS) was conducted to assess the Society's member's opinions on treatment.
Methods: A survey was sent by mail to 1837 members of the ASBS. The survey consisted of a brief case presentation after which the surgeon's preference for management of the breast was sought. The choices included "mastectomy," "whole breast radiation" or "other."
Results: A total of 776 (42%) responses were received. The majority of respondents, 338 or 43%, preferred "mastectomy," while 285 or 37% opted for "whole breast radiation." Twenty percent of respondents (153 responses) chose "other," of which 46 physicians (6% of total) indicated they would observe the patient.
Conclusions: Although recent literature supports the use of whole breast radiation, these results demonstrate that a small majority of physicians still prefer mastectomy. The appropriate treatment of the breast after an axillary presentation of OBC continues to be a controversial issue.
Xie X, Kong X, Jiang H, Gao J Front Oncol. 2025; 15:1374032.
PMID: 40008002 PMC: 11851083. DOI: 10.3389/fonc.2025.1374032.
Occult breast cancer in an older woman: A case report.
Liu C, Xing H Exp Ther Med. 2025; 29(2):38.
PMID: 39781192 PMC: 11707571. DOI: 10.3892/etm.2024.12788.
Trends in management and related outcomes for occult primary breast cancer.
LaBella M, Lile-King R, Agala C, Spanheimer P, Ollila D, Gallagher K Breast Cancer Res Treat. 2024; 209(2):367-374.
PMID: 39397208 PMC: 11875011. DOI: 10.1007/s10549-024-07500-w.
Tang L, Zhu Y, Du Y, Long X, Long Y, Tang Y J Cancer Res Clin Oncol. 2024; 150(5):256.
PMID: 38750402 PMC: 11096249. DOI: 10.1007/s00432-024-05783-6.
Occult breast cancer with pleural metastasis.
Faghani R, Monadi S Radiol Case Rep. 2023; 18(9):3065-3069.
PMID: 37434614 PMC: 10331009. DOI: 10.1016/j.radcr.2023.06.001.